Targeted repression of AXIN2 and MYC gene expression using designer TALEs

Biochemical and Biophysical Research Communications

Volumn 446, Issue 4, 2014, Pages 1120-1125

  Rennoll, Sherri A ^a   Scott, Samantha A ^a   Yochum, Gregory S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

AXIN2; MYC; SID; TALE; Wnt; Catenin

Indexed keywords

AXIN2; MYC; SID; TALE; WNT; Β-CATENIN;

AXIN PROTEIN; BASE SEQUENCE; BETA CATENIN; BINDING SITES; DOWN-REGULATION; GENES, MYC; HEK293 CELLS; HUMANS; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 84899489011     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.03.077     Document Type: Article

References (27)

1. A.J. Bogdanove, and D.F. Voytas TAL effectors: customizable proteins for DNA targeting Science 333 2011 1843 1846
2. L. Cong, R. Zhou, Y.C. Kuo, M. Cunniff, and F. Zhang Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains Nat. Commun. 3 2012 968
3. X. Gao, J. Yang, J.C. Tsang, J. Ooi, D. Wu, and P. Liu Reprogramming to pluripotency using designer TALE transcription factors targeting enhancers Stem Cell Rep. 1 2013 183 197
4. Z. Zhang, D. Xiang, F. Heriyanto, Y. Gao, Z. Qian, and W.S. Wu Dissecting the roles of miR-302/367 cluster in cellular reprogramming using TALE-based repressor and TALEN Stem Cell Rep. 1 2013 218 225
5. D.E. Ayer, Q.A. Lawrence, and R.N. Eisenman Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3 Cell 80 1995 767 776
6. A.L. Eilers, A.N. Billin, J. Liu, and D.E. Ayer A 13-amino acid amphipathic alpha-helix is required for the functional interaction between the transcriptional repressor Mad1 and mSin3A J. Biol. Chem. 274 1999 32750 32756
7. B.T. MacDonald, K. Tamai, and X. He Wnt/beta-catenin signaling: components, mechanisms, and diseases Dev. Cell 17 2009 9 26
8. C. Mosimann, G. Hausmann, and K. Basler Beta-catenin hits chromatin: regulation of Wnt target gene activation Nat. Rev. Mol. Cell Biol. 10 2009 276 286
9. E.R. Fearon Molecular genetics of colorectal cancer Annu. Rev. Pathol. 6 2011 479 507
10. T.C. He, A.B. Sparks, C. Rago, H. Hermeking, L. Zawel, L.T. da Costa, P.J. Morin, B. Vogelstein, and K.W. Kinzler Identification of c-MYC as a target of the APC pathway Science 281 1998 1509 1512
11. E.H. Jho, T. Zhang, C. Domon, C.K. Joo, J.N. Freund, and F. Costantini Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway Mol. Cell. Biol. 22 2002 1172 1183
12. J.Y. Leung, F.T. Kolligs, R. Wu, Y. Zhai, R. Kuick, S. Hanash, K.R. Cho, and E.R. Fearon Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling J. Biol. Chem. 277 2002 21657 21665
13. B. Lustig, B. Jerchow, M. Sachs, S. Weiler, T. Pietsch, U. Karsten, M. van de Wetering, H. Clevers, P.M. Schlag, W. Birchmeier, and J. Behrens Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors Mol. Cell. Biol. 22 2002 1184 1193
14. G.S. Yochum, R. Cleland, and R.H. Goodman A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression Mol. Cell. Biol. 28 2008 7368 7379
15. D. Bottomly, S.L. Kyler, S.K. McWeeney, and G.S. Yochum Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq Nucleic Acids Res. 38 2010 5735 5745
16. P. Hatzis, L.G. van der Flier, M.A. van Driel, V. Guryev, F. Nielsen, S. Denissov, I.J. Nijman, J. Koster, E.E. Santo, W. Welboren, R. Versteeg, E. Cuppen, M. van de Wetering, H. Clevers, and H.G. Stunnenberg Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells Mol. Cell. Biol. 28 2008 2732 2744
17. C.V. Dang, K.A. O'Donnell, K.I. Zeller, T. Nguyen, R.C. Osthus, and F. Li The c-Myc target gene network Semin. Cancer Biol. 16 2006 253 264
18. S. Tuupanen, M. Turunen, R. Lehtonen, O. Hallikas, S. Vanharanta, T. Kivioja, M. Bjorklund, G. Wei, J. Yan, I. Niittymaki, J.P. Mecklin, H. Jarvinen, A. Ristimaki, M. Di-Bernardo, P. East, L. Carvajal-Carmona, R.S. Houlston, I. Tomlinson, K. Palin, E. Ukkonen, A. Karhu, J. Taipale, and L.A. Aaltonen The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling Nat. Genet. 41 2009 885 890
19. G.S. Yochum Multiple Wnt/beta-catenin responsive enhancers align with the MYC promoter through long-range chromatin loops PLoS ONE 2011 e18966
20. W.M. Konsavage Jr., S.L. Kyler, S.A. Rennoll, G. Jin, and G.S. Yochum Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells J. Biol. Chem. 287 2012 11730 11739
21. G.S. Yochum, R. Cleland, S. McWeeney, and R.H. Goodman An antisense transcript induced by Wnt/beta-catenin signaling decreases E2F4 J. Biol. Chem. 282 2007 871 878
22. G.S. Yochum, and D.E. Ayer Pf1, a novel PHD zinc finger protein that links the TLE corepressor to the mSin3A-histone deacetylase complex Mol. Cell. Biol. 21 2001 4110 4118
23. D. Reyon, S.Q. Tsai, C. Khayter, J.A. Foden, J.D. Sander, and J.K. Joung FLASH assembly of TALENs for high-throughput genome editing Nat. Biotechnol. 30 2012 460 465
24. -/- colon carcinoma Science 275 1997 1784 1787
25. N.D. Heintzman, R.K. Stuart, G. Hon, Y. Fu, C.W. Ching, R.D. Hawkins, L.O. Barrera, S. Van Calcar, C. Qu, K.A. Ching, W. Wang, Z. Weng, R.D. Green, G.E. Crawford, and B. Ren Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome Nat. Genet. 39 2007 311 318
26. E.M. Mendenhall, K.E. Williamson, D. Reyon, J.Y. Zou, O. Ram, J.K. Joung, and B.E. Bernstein Locus-specific editing of histone modifications at endogenous enhancers Nat. Biotechnol. 31 2013 1133 1136
27. F. Zhang, L. Cong, S. Lodato, S. Kosuri, G.M. Church, and P. Arlotta Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription Nat. Biotechnol. 29 2011 149 153